These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34175865)

  • 1. Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.
    Haberman RH; Jaros BD; Scher JU
    Curr Opin Rheumatol; 2021 Sep; 33(5):409-411. PubMed ID: 34175865
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
    Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
    Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
    [No Abstract]   [Full Text] [Related]  

  • 3. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Jan; 80(1):e3. PubMed ID: 32340978
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
    Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
    Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
    Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
    Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How did COVID-19 pandemic changed the Portuguese rheumatology?
    Vieira-Sousa E; Fonseca JE; Santos MJ
    Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
    [No Abstract]   [Full Text] [Related]  

  • 9. The Impact of the Off-site Monitoring Clinic (Virtual Monitoring Clinic) on the Practice of Outpatient Rheumatology in a Tertiary Centre during the COVID-19 Pandemic.
    Chew LC; Yeo SI; Thumboo J
    Ann Acad Med Singap; 2020 Nov; 49(11):905-908. PubMed ID: 33381785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
    Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
    Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Dec; 24(12):1547. PubMed ID: 34854242
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
    Saldarriaga Rivera LM; Fernández Ávila D; Bautista Molano W; Jaramillo Arroyave D; Bautista Ramírez AJ; Díaz Maldonado A; Hernán Izquierdo J; Jáuregui E; Latorre Muñoz MC; Restrepo JP; Segura Charry JS
    Reumatol Clin (Engl Ed); 2020; 16(6):437-446. PubMed ID: 32800760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing rheumatic diseases during COVID-19.
    Ladani AP; Loganathan M; Danve A
    Clin Rheumatol; 2020 Nov; 39(11):3245-3254. PubMed ID: 32895747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: What Do Rheumatologists Need to Know?
    Fitzgerald GE; Maguire S; Haroon N
    Curr Rheumatol Rep; 2021 Jan; 23(1):5. PubMed ID: 33403528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.
    Seo MR; Kim JW; Park EJ; Jung SM; Sung YK; Kim H; Kim G; Kim HS; Lee MS; Lee J; Hur JA; Chin BS; Eom JS; Baek HJ;
    Korean J Intern Med; 2020 Nov; 35(6):1317-1332. PubMed ID: 32972125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease.
    D'Silva KM; Serling-Boyd N; Hsu TY; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2021 Jun; 80(6):817-819. PubMed ID: 33436385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.